You are here

  • Home
  • Archive
  • Volume 71, Issue Suppl 3
  • AB1064 No clinically meaningful drug interactions expected between lesinurad, a novel oral uricosuric agent, and drugs most commonly used by gout patients

Article metrics

Article menu
Download PDFPDF
Scientific Abstracts
Abstracts accepted for publication
Bone diseases other than osteoporosis, metabolic diseases and crystal diseases
AB1064 No clinically meaningful drug interactions expected between lesinurad, a novel oral uricosuric agent, and drugs most commonly used by gout patients

 

Online download statistics by month:

Online download statistics by month: February 2014 to March 2024

AbstractFullPdf
Feb 2014402
Mar 20141505
Apr 20141400
May 2014300
Jun 2014300
Jul 2014600
Sep 20141101
Oct 2014500
Nov 2014801
Dec 2014500
Feb 2015500
Mar 2015201
Apr 20151201
May 2015300
Jun 2015400
Jul 2015500
Aug 20151901
Sep 20151600
Oct 2015701
Nov 20152904
Dec 20151301
Jan 20162000
Feb 20163405
Mar 20161701
Apr 20161903
May 20161205
Jun 2016400
Jul 2016902
Aug 20162301
Sep 20162401
Oct 20161400
Nov 2016700
Dec 2016500
Jan 20171901
Feb 2017300
Mar 2017400
Apr 20171601
May 2017800
Jun 2017802
Jul 2017800
Aug 20171400
Sep 20171405
Oct 2017400
Nov 20171000
Dec 20171200
Jan 2018801
Feb 2018402
Mar 2018600
Apr 20181200
May 20181200
Jun 2018600
Jul 2018800
Aug 20181200
Sep 2018200
Oct 2018400
Nov 2018200
Dec 2018800
Jan 2019400
Apr 2019200
May 2019400
Jun 2019200
Jul 2019200
Oct 2019301
Nov 2019100
Dec 2019100
Feb 2020200
Mar 2020700
Jun 2020400
Jul 2020800
Sep 20201001
Oct 2020200
Nov 2020400
Jan 2021400
Mar 2021200
Apr 2021400
May 2021100
Jul 2021300
Aug 2021100
Sep 2021300
Oct 2021800
Nov 2021201
Dec 2021900
Jan 2022200
Feb 2022400
Apr 2022800
May 2022800
Jun 2022200
Jul 20221600
Aug 20221000
Sep 2022400
Oct 2022200
Nov 2022800
Dec 20221900
Jan 2023200
Feb 2023600
Mar 2023600
May 2023400
Jul 2023200
Sep 2023800
Nov 2023200
Dec 2023400
Jan 2024200
Feb 20241000
Mar 2024200
Total805051